BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. (Q40294208)

19 September 2017

title

BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. (English)

1 reference

19 September 2017

main subject

chronic myeloid leukemia

0 references

1 reference

14

1 reference

19 September 2017

15

1 reference

Crescenzio Francesco Minervini

19 September 2017

Nicoletta Coccaro

3

0 references

object named as

Crescenzio Francesco Minervini

10

0 references

Luisa Anelli

object named as

Luisa Anelli

2

0 references

Antonella Zagaria

object named as

Antonella Zagaria

1

0 references

author name string

Giuseppina Tota

4

1 reference

19 September 2017

Paola Casieri

5

1 reference

19 September 2017

Angelo Cellamare

6

1 reference

19 September 2017

Luciana Impera

7

1 reference

19 September 2017

Claudia Brunetti

8

1 reference

19 September 2017

Angela Minervini

9

1 reference

19 September 2017

Mario Delia

11

1 reference

19 September 2017

Cosimo Cumbo

12

1 reference

19 September 2017

Paola Orsini

13

1 reference

19 September 2017

publication date

7 July 2015

1 reference

19 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Virchows Archiv

1 reference

19 September 2017

volume

467

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

357-363

1 reference

describes a project that uses

19 September 2017

1 reference

Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

BCR/ABL1 fusion transcripts generated from alternative splicing: implications for future targeted therapies in Ph+ leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Absolute quantification by droplet digital PCR versus analog real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Identification of an acute basophilic leukaemia carrying a rare e6a2 BCR-ABL transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

“Home-brew” FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-015-1802-Z

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia

21 January 2018

1 reference

12 December 2020

Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.

1 reference

12 December 2020

e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia

1 reference

12 December 2020

Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

1 reference

12 December 2020

The molecular biology of chronic myeloid leukemia.

1 reference

12 December 2020

CML with e6a2 BCR-ABL1 transcript: an aggressive entity?

1 reference

12 December 2020

The BCR gene and philadelphia chromosome-positive leukemogenesis.

1 reference

12 December 2020

A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients

1 reference

12 December 2020

e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?

1 reference

12 December 2020

Quantitation of targets for PCR by use of limiting dilution

1 reference

12 December 2020

Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report

1 reference

12 December 2020

An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation

1 reference

12 December 2020

Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation

1 reference

12 December 2020

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

1 reference

12 December 2020

A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment

1 reference

12 December 2020

10.1007/S00428-015-1802-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1033956565

0 references

1 reference